spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

EXTERNAL COMMUNICATION, 24 October 2019, Copenhagen, Denmark PRESS RELEASE – FLYPHARMA CONFERENCE EUROPE 2019

FlyPharma

FlyPharma Europe 2019 – Latest supply chain challenges and industry best practices

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges and industry best practices, putting together a global audience of (bio)pharma and logistics professionals. The two-day conference (22-23 October 2019) aimed to discuss the collaboration and growth within Scandinavia, with a special focus on women in pharmaceutical logistics and an exploration of the industry’s digitalisation and innovation.

This year, SAS Cargo kindly stepped up to be FlyPharma Europe’s Host Sponsor, being an excellent match for FlyPharma as a growing industry force in pharmaceutical product transportation. FlyPharma had the pleasure of having its evening networking event at the end of Day 1 sponsored by DSV, trusted supply chain solutions providers to the pharmaceutical and healthcare industry, and its networking breaks sponsored by GEFCO – world leader in complex supply chain solutions.

FlyPharma welcomed over 150 advocates of the pharmaceutical logistics industry, including speakers who shared their expertise on innovative digital technologies, how to master the supply chain, and how to spot the opportunities within the sector and address its challenges. The conference was animated by joint presentations, various case studies and panel discussions, during which attendees were invited to interact, comment with their own views and were encouraged to ask questions. Being lively and entertaining, those sessions seemed to be considerably appreciated by the audience who could participate and be involved in the conversations.

FlyPharma Europe 2019 decided to focus on the Nordics and let some of the region’s specialists share advice regarding business opportunities in Greater Copenhagen and explain how it is involved in the pharmaceutical industry. For instance, the conference welcomed Medicon Valley Alliance’s Chief Executive Officer, Petter Hartman, who explained to the attendees why the organization is ‘The leading life science cluster of the Nordics’, giving details on Medicon Valley Alliance’s ecosystem key drivers and offering an overview of the major investments and state-of-the-art research infrastructure in the region.

On Day 2 of the conference, attendees were offered the opportunity to attend a site tour of Copenhagen Airport to take a closer look at the airport’s pharmaceutical cargo facilities and to discover first-hand how Copenhagen Airport and its operators provide high-quality cargo handling for their pharma customers. Copenhagen Airport Cargo Managers shared their knowledge of the airport facilities and entertained participants with some site anecdotes for two and a half hours. The tour also involved visiting World Flight Services’ and Spirit Air Cargo Handling’s facilities to give participants a better understanding of the term ‘temperature controlled’ when it comes to pharmaceutical storage.

FlyPharma Europe 2019’s Copenhagen location was an opportunity to tackle brand new topics and challenges faced in the Nordics with specialists from key companies of the industry, willing to inform the audience with well-structured presentations and who were happy to answer any questions asked.

FlyPharma Europe will return for its sixth year in 2020 – date and location to be confirmed soon. FlyPharma Asia also returns for its second year in 2020, with full details to be revealed soon. 

Visit the FlyPharma Europe website www.FlyPharmaEurope.com for more details on this event and to register your interest for future conferences.

Contact Information

Angela Cottrell, Events & Editorial Director, email: angela@samedanltd.com
Eva Brossin, Events & Admin Assistant, email: eva@samedanltd.com
email flypharma@samedanltd.com
web www.FlyPharmaEurope.com
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Significant improvement in overall survival with ERLEADA®▼ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer

BEERSE, BELGIUM, May 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA®▼ (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.1 Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Programme (Abstract #5516) beginning on Friday 29th May.
More info >>


White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>

Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement